achieved a highly significant reduction of total nasal symptom scores (TNSS) in their clinical trials for cat allergen induced allergic rhinitis [ 10 , 11 ], and their antibodies significantly prevented reductions of FEV1 in cat allergic asthma patients in cat exposure chambers [ 57 ].
1
—
—